SEARCH RESULTS FOR: "Tag: ABBV"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2021(1)
2020(3)
2019(11)
2018(10)
2017(4)
2016(5)
2015(10)
2014(8)
CATEGORIES
Analyst Downgrades(1)
Analyst Update(7)
Analyst Upgrades(2)
Bernie's Content(1)
Buzz Stocks(9)
By the Numbers(1)
Early Edge(1)
Earnings Preview(1)
Expectational Analysis(1)
General(12)
Indicator of the Week(1)
Intraday Option Activity(5)
Midday Market Check(2)
Opening View(4)
Quantitative Analysis(1)
Stock Market News(1)
Stocks On the Move(9)
Technical Analysis(2)
Trade Postmortem(1)
Unusual Trading Activity(1)

3/16/2021 10:19 AM
AbbVie Inc (NYSE:ABBV) is in the spotlight this morning, after news that the pharmaceutical company is in talks to sell a $5 billion portfolio of women's drugs. According to Reuters, the company acqui...
10/30/2020 8:06 AM
Yesterday's upbeat economic data lifted the market. U.S. gross domestic product (GDP) data came in better than expected, posting its fastest expansion ever, while initial jobless claims fell to 751,00...
6/25/2020 2:21 PM
Last time we checked in on AbbVie Inc (NYSE:ABBV), the company announced an oncology collaboration with biotech company Genmab (GMAB). Today, the drugmaker agreed to another collaboration, this time w...
6/10/2020 11:00 AM
The shares of biopharmaceutical company AbbVie Inc (NYSE:ABBV) are up 2.1% at $98.16 at last check, after announcing an oncology collaboration with Genmab (GMAB). The companies will work together to d...
10/15/2019 10:10 AM
The shares of Reata Pharmaceuticals Inc (NASDAQ:RETA) have skyrocketed 46.7% to trade at $147.57, and earlier touched a record high of $149.80, thanks to strong data on the company's degenerative n...
 
Special Offers from Schaeffer's Trading Partners